Charles Schwab’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-33,139
| Closed | -$386K | – | 3700 |
|
2022
Q1 | $386K | Buy |
33,139
+5,593
| +20% | +$65.1K | ﹤0.01% | 3155 |
|
2021
Q4 | $503K | Hold |
27,546
| – | – | ﹤0.01% | 3144 |
|
2021
Q3 | $327K | Sell |
27,546
-55,418
| -67% | -$658K | ﹤0.01% | 3248 |
|
2021
Q2 | $1.43M | Buy |
82,964
+10,036
| +14% | +$173K | ﹤0.01% | 2816 |
|
2021
Q1 | $1.33M | Buy |
72,928
+2,917
| +4% | +$53.4K | ﹤0.01% | 2761 |
|
2020
Q4 | $1.32M | Buy |
70,011
+1,303
| +2% | +$24.5K | ﹤0.01% | 2697 |
|
2020
Q3 | $1.45M | Buy |
68,708
+53,876
| +363% | +$1.14M | ﹤0.01% | 2587 |
|
2020
Q2 | $429K | Buy |
14,832
+2,833
| +24% | +$81.9K | ﹤0.01% | 2896 |
|
2020
Q1 | $420K | Hold |
11,999
| – | – | ﹤0.01% | 2773 |
|
2019
Q4 | $294K | Buy |
+11,999
| New | +$294K | ﹤0.01% | 2978 |
|